您的位置: 首页 > 2021年11月 第52卷 第6期 > 文字全文
2023年7月 第38卷 第7期11
目录

超声-微泡介导miR-128通过调节PTEN抑制乳腺癌细胞阿霉素耐药

Ultrasound-microbubble mediated miR-128 inhibited doxorubicin resistance in breast cancer cells by regulating PTEN

来源期刊: 广州医药 | 35-38 发布时间:2021-11-26 收稿时间:2025/11/13 18:01:24 阅读量:25
作者:
关键词:
乳腺癌超声微泡miR-128PTEN
breast cancerultrasound-microbubblemiR-128PTEN
DOI:
10.3969/j.issn.1000-8535.2021.06.007
收稿时间:
2021-02-11 
修订日期:
 
接收日期:
 
引用总数:
0  
目的 探究超声-微泡介导的miR-128通过调节PTEN对乳腺癌细胞阿霉素耐药的影响。方法 qPCR检测miR-128在乳腺癌细胞系中的表达,并利用结合微泡的miR-128质粒(质粒+超声+SF6微泡)转染细胞,探究超声-微泡介导的miR-128对乳腺癌细胞阿霉素耐药的影响。CCK8实验检测乳腺癌细胞的活性;qPCR检测过表达miR-128后对PTEN的影响和对乳腺癌细胞阿霉素耐药的影响。结果 miR-128在阿霉素耐药乳腺癌细胞中低表达;过表达miR-128能够增加乳腺癌细胞对阿霉素的敏感性,超声-微泡介导的miR-128进一步增强了乳腺癌细胞对阿霉素的敏感性;miR-128通过调节PTEN从而促进乳腺癌细胞对阿霉素耐药。结论 miR-128过表达可以增强乳腺癌对阿霉素的敏感性,超声-微泡介导的miR-128进一步增强了乳腺癌细胞对阿霉素的敏感性,本研究为乳腺癌阿霉素耐药的治疗提供了新的分子靶标和治疗途径。
Objective To explore the effect of ultrasound-microbubble mediated miR-128 on doxorubicin resistance in breast cancer cells by regulating PTEN. Methods Quantitatine PCR (qPCR) was used to detect the expression of miR-128 in breast cancer cell lines, and the ultrasound-microbubble combined miR-128 plasmid(plasmid+ultrasound+SF6 microbubbles) was used to transfect the cells to explore the effects of ultrasound-microbubble mediated miR-128 on doxorubicin resistance in cancer cells. The CCK8 experiment was used to detect the activity of breast cancer cells; qPCR was used to detect the effect of overexpression of miR-128 on PTEN and the effect on doxorubicin resistance of breast cancer cells. Results miR-128 was under-expressed in doxorubicin-resistant breast cancer cells; overexpression of miR-128 increased the sensitivity of breast cancer cells to doxorubicin,ultrasound-microbubble mediated miR-128 further enhanced breast cancer cells sensitivity to doxorubicin; miR-128 promote resistance to doxorubicin in breast cancer cells by regulating PTEN. Conclusion Overexpression of miR-128 could enhance the sensitivity of breast cancer to doxorubicin. Ultrasound-microbubble mediated miR-128 further enhanced the sensitivity. This study provided a treatment for doxorubicin resistance in breast cancer with new molecular targets and therapeutic approaches.
1、 YANG C, LI B, YU J, et al. Ultrasound microbubbles mediated miR-let-7b delivery into CD133(+) ovarian cancer stem cells [J]. Biosci Rep, 2018, 38(5): BSR20180922. YANG C, LI B, YU J, et al. Ultrasound microbubbles mediated miR-let-7b delivery into CD133(+) ovarian cancer stem cells [J]. Biosci Rep, 2018, 38(5): BSR20180922.
2、 QIN D, LI H, XIE H. Ultrasound-targeted microbubble destruction-mediated miR-205 enhances cisplatin cytotoxicity in prostate cancer cells [J]. Mol Med Rep, 2018, 18(3): 3242-3250. QIN D, LI H, XIE H. Ultrasound-targeted microbubble destruction-mediated miR-205 enhances cisplatin cytotoxicity in prostate cancer cells [J]. Mol Med Rep, 2018, 18(3): 3242-3250.
3、 KHAYAMIAN M A, ANSARYAN S, TAFTI S R, et al. Ultrasound assisted electrochemical distinction of normal and cancerous cells [J]. Sens Actuators B Chem, 2018, 255(1):1-7. KHAYAMIAN M A, ANSARYAN S, TAFTI S R, et al. Ultrasound assisted electrochemical distinction of normal and cancerous cells [J]. Sens Actuators B Chem, 2018, 255(1):1-7.
4、 陈元元, 唐铁雷, 程永刚,等. miR-148a-3p、miR-128、miR-588在乳腺癌中的表达情况及其与耐药性的关系 [J].现代肿瘤医学,2019, 27(12): 2108-2113. 陈元元, 唐铁雷, 程永刚,等. miR-148a-3p、miR-128、miR-588在乳腺癌中的表达情况及其与耐药性的关系 [J].现代肿瘤医学,2019, 27(12): 2108-2113.
5、 TAKAHASHI Y, IWAYA T, SAWADA G, et al. Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer [J]. Ann Surg Oncol, 2014, 21(1): 205-212. TAKAHASHI Y, IWAYA T, SAWADA G, et al. Up-regulation of NEK2 by microRNA-128 methylation is associated with poor prognosis in colorectal cancer [J]. Ann Surg Oncol, 2014, 21(1): 205-212.
6、 佘晓玲. miR-128、miR-149和miR-181靶向抑制Rap1B影响脑胶质瘤细胞增殖、侵袭及化疗敏感性的机制研究 [D].长沙:中南大学, 2014. 佘晓玲. miR-128、miR-149和miR-181靶向抑制Rap1B影响脑胶质瘤细胞增殖、侵袭及化疗敏感性的机制研究 [D].长沙:中南大学, 2014.
7、 叶彦军, 郝福军, 陈巍, 等. miR-128通过RECK靶向作用影响乳腺癌细胞的生物学行为 [J]. 局解手术学杂志,2018, 27(10): 707-710. 叶彦军, 郝福军, 陈巍, 等. miR-128通过RECK靶向作用影响乳腺癌细胞的生物学行为 [J]. 局解手术学杂志,2018, 27(10): 707-710.
8、 ELLIS H, MA C X. PI3K Inhibitors in breast cancer therapy [J]. Current Oncol Rep, 2019, 21(12): 110. ELLIS H, MA C X. PI3K Inhibitors in breast cancer therapy [J]. Current Oncol Rep, 2019, 21(12): 110.
9、 ANASTASIADI Z, LIANOS G D, IGNATIADOU E, et al. Breast cancer in young women: an overview [J]. Updates Surg, 2017, 69(3): 313-317. ANASTASIADI Z, LIANOS G D, IGNATIADOU E, et al. Breast cancer in young women: an overview [J]. Updates Surg, 2017, 69(3): 313-317.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录